Bacteriophages have been used therapeutically to treat infectious bacterial diseases for over a century. As ...

A bacterial cell settles onto a nondescript surface. It is plump, healthy and functioning as it should. Nothing appears amiss ...

Near-weightless conditions can mutate genes and alter the physical structures of bacteria and phages, disrupting their normal ...

A bacterial defense system called SPARDA employs kamikaze-like tactics to protect cells and could be useful in future ...

Basilea Pharmaceutica has partnered with INCATE, the European incubator for antibacterial therapies, to support the advancement of early-stage anti-infective innovations. As an industry partner, ...

This article is based on a poster originally authored by Krishna Macha, Sushmita Sudarshan, Carina Gao, Oksana Sirenko, and Sheela Muley. Bacterial and yeast strains are central to microbiology, ...

Basilea Pharmaceutica has entered into a strategic collaboration with Prokaryotics to develop a first-in-class broad-spectrum antifungal therapy targeting severe invasive fungal infections. The ...

* 1-year performance calculated using Jan. 2 as the reference date. Vaxcyte is a clinical-stage biotechnology company specializing in the development of next-generation protein vaccines to address ...

Evaxion Biotech ( (EVAX)) has issued an update. On November 6, 2025, Evaxion A/S announced significant business developments and financial results for the third quarter of 2025. Key highlights include ...

As "superbugs" continue to surge, the World Health Organization is now warning that one in every six bacterial infections are resistant to antibiotics. WHO also called for antibiotic medications to be ...